Study of Zonisamide for partial seizures in children
Part of Brain & nervous system clinical trials.
This trial tests a liquid medication called ZONISADE (zonisamide) for children aged 1 month to 17 years who have partial-onset seizures. It aims to see how the drug works in the body and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 1 month and 17 years old.
- Your child has partial-onset (focal) seizures, which start in one part of the brain, and may spread.
- Your child has had seizures more than once in the last 3 months and more than twice in the last 6 months.
- Your child is on stable seizure medications for at least 30 days before starting.
- Your child has normal blood test results for hemoglobin, liver enzymes, and kidney function.
- If your child can have children, they must use effective birth control or be abstinent during the trial and for 1 month after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding zonisamide to the current epilepsy medication for children aged 1 to 14 who still have focal seizures. The goal is to see if the combination works better and is safe.
This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.
This trial studies the best dose of a seizure medicine for children who are actively seizing while emergency medical teams are treating them. It may help EMS crews give safer, more effective treatment during transport.
This trial tests a new implanted device that detects and stops seizures before they spread. It is for people with difficult-to-control focal seizures who have not had success with medicines.
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
This study tests whether a new medication called RAP-219 can help adults with focal seizures (seizures that start in one area of the brain) control their seizures better. You would take this medication alongside your current seizure drugs for about 12 weeks.
Hear when a new Seizures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.